In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation Joanne I. BrodfüehrerDavid J. MooreGarth Powis Preclinical Studies Pages: 3 - 9
Use of human neuroblastoma continuous cell lines for in vitro drug sensitivity screening Bridget T. HillR. D. H. WhelanLouise K. Hosking Preclinical Studies Pages: 11 - 18
Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU) Beryl Hartley-AspP. -I. ChristenssonA. Stamvik Pharmacology Studies Pages: 19 - 30
Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors Faith KungF. Ann HayesStuart Toledano OriginalPaper Pages: 31 - 36
Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma Edwin B. CoxCharles L. VogelMarilyn Raney OriginalPaper Pages: 37 - 40
Phase I–II trial of acivicin in adult acute leukemia Bayard L. PowellJohn B. CraigFrederick Richards II OriginalPaper Pages: 41 - 44
Evaluation of fludarabine phosphate in small cell carcinoma John M. RaineyJulian B. HillJohn Crowley OriginalPaper Pages: 45 - 46
Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma Jaffer A. AjaniJames L. AbbruzzeseBruce M. Boman OriginalPaper Pages: 47 - 50
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial Scott M. LippmanJohn F. KasslerFrank L. Meyskens Jr. OriginalPaper Pages: 51 - 56
Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma Aristidis PolyzosSewa S. LeghaGerald P. Bodey OriginalPaper Pages: 57 - 61